China NMPA Drug Inspection - Disa Pharmaceutical Group Co., Ltd. - Roxithromycin Dispersible Tablets
China NMPA drug inspection for Disa Pharmaceutical Group Co., Ltd. published August 27, 2020. Drug: Roxithromycin Dispersible Tablets. On August 27, 2020, the Shaanxi Provincial Drug Administration published a drug quality announcement detailing results f
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Disa Pharmaceutical Group Co., Ltd. published August 27, 2020. Drug: Roxithromycin Dispersible Tablets. On August 27, 2020, the Shaanxi Provincial Drug Administration published a drug quality announcement detailing results f
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox